Pfizer (PFE) agreed to buy Seagen (SGEN) for $43B. Stewart Glickman discusses this as CFRA has a buy rating on PFE. The CFRA analyst notes that they expect the deal to close by early 2024, dependent on both shareholder and regulatory approval. They think that the market is pricing in some concern over antitrust hurdles. He then goes over other health care stocks to watch. Tune in to find out more about the stock market today.
14 Mar 2023
Market On Close
10 Aug 2023
The Watch List
12 Sep 2023
Fast Market
13 Sep 2023
Trading 360
03 Aug 2023
Morning Trade Live
18 Aug 2023